Literature DB >> 22675096

Overwhelming primary Epstein-Barr virus infection requiring corticosteroid treatment.

Marije Gordinou de Gouberville1, Martien Janssen, Anita Schrander-van der Meer, Matthijs Eefting, Nathalie Delfos, Cees van Nieuwkoop.   

Abstract

A 20-year-old woman presented with a 2-week history of fever and malaise. Physical examination was unremarkable. Viral infection was suspected and Epstein-Barr virus serology confirmed acute infectious mononucleosis. During admission, she gradually developed pancytopenia and liver enzyme abnormalities. The patient clinically deteriorated with persisting fever, orthostatic hypotension and hepatosplenomegaly. Bone marrow examination showed haemophagocytic lymphohistiocytosis (HLH). Treatment with high-dose corticosteroids was started and patient recovered quickly. Ferritin decreased immediately, fever resolved within 3 days, viral clearance was reached within 3 weeks. Steroid therapy was gradually tapered off in three months. The Histiocyte Society recommends immunochemotherapy with steroids, etoposide and cyclosporine. Potential side effects of etoposide are severe bone marrow depression and leukaemia. Our patient survived on corticosteroids alone. Early recognition of HLH and prompt treatment are of utmost importance for survival. Treatment with steroids alone can be life-saving.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22675096      PMCID: PMC3207790          DOI: 10.1136/bcr.08.2011.4643

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  S Imashuku; K Kuriyama; T Teramura; E Ishii; N Kinugawa; M Kato; M Sako; S Hibi
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

Review 2.  Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

Authors:  Yoshihito Kasahara; Akihiro Yachie
Journal:  Crit Rev Oncol Hematol       Date:  2002-12       Impact factor: 6.312

3.  Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  Shinsaku Imashuku; Tomoko Teramura; Hisamichi Tauchi; Yasushi Ishida; Yoshiko Otoh; Machiko Sawada; Haruki Tanaka; Arata Watanabe; Yasuhiro Tabata; Akira Morimoto; Shigeyoshi Hibi; Jan-Inge Henter
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

4.  Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  Brian Belyea; Ashley Hinson; Cassandra Moran; Eugene Hwang; Jessica Heath; Raymond Barfield
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

5.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 6.  Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis.

Authors:  G Janka; S Imashuku; G Elinder; M Schneider; J I Henter
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

7.  Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.

Authors:  I J Su; R L Chen; D T Lin; K S Lin; C C Chen
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.

Authors:  Jin-Seok Lee; Jin-Han Kang; Geon-Kook Lee; Hyeon-Jin Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis.

Authors:  Abha Gupta; Pascal Tyrrell; Rahim Valani; Susanne Benseler; Sheila Weitzman; Mohamed Abdelhaleem
Journal:  Pediatr Blood Cancer       Date:  2008-09       Impact factor: 3.167

10.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

Authors:  C H Pui; R C Ribeiro; M L Hancock; G K Rivera; W E Evans; S C Raimondi; D R Head; F G Behm; M H Mahmoud; J T Sandlund
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.